Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke

New England Journal of Medicine

Volumn 347, Issue 6, 2002, Pages 395-400

  Brashear, Allison ^a,g   Gordon, Mark F ^b   Elovic, Elie ^c   Kassicieh, V Daniel ^d   Marciniak, Christina ^e   Do, Mai ^f   Lee, Chia Ho ^c,d   Jenkins, Stephen ^d,e   Turkel, Catherine ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c KESSLER FOUNDATION   (United States)

^d Neurological Research Institute of Sarasota   (United States)

^e REHABILITATION INSTITUTE OF CHICAGO   (United States)

^f ALLERGAN INC   (United States)

^g INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; AGED; ARTICLE; BODY POSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECCHYMOSIS; FEMALE; FINGER; FLEXION CONTRACTURE; FOLLOW UP; HEADACHE; HUMAN; HYPESTHESIA; INFECTION; LIMB MOVEMENT; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; MUSCLE TONE; MUSCLE WEAKNESS; PAIN; PAIN ASSESSMENT; PERSONAL HYGIENE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF CARE; SELF REPORT; SPASTICITY; STATISTICAL ANALYSIS; STROKE; TREATMENT OUTCOME; VERTIGO; WRIST DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BOTULINUM TOXIN TYPE A; CEREBROVASCULAR ACCIDENT; DISABLED PERSONS; DOUBLE-BLIND METHOD; FEMALE; FINGERS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; RECOVERY OF FUNCTION; WRIST;

EID: 0037043682     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa011892     Document Type: Article

References (23)

1. The current neurologic burden of illness and injury in the United States
2. Common patterns of clinical motor dysfunction
3. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
4. Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients
5. Management of muscle spasticity
6. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb
7. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury
8. Management of spasticity associated pain with botulinum toxin A
9. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial
10. Preliminary trial of carisoprodol in multiple sclerosis
11. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity
12. A multicenter, double-blind, placebo-controlled dose response trial of botulinum toxin type A (Botox) in upper limb spasticity post-stroke
13. The inter-rater and intra-rater reliability of the Ashworth Scale and Disability Assessment Scale in patients with upper-limb post-stroke spasticity
14. Continuous intrathecal baclofen infusion for spasticity of cerebral origin
15. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia
16. Immunogenicity of the neurotoxins of Clostridium botulinum
17. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults
18. Spasticity: A review
19. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke
20. Current trends in the management of spasticity
21. A clinical overview of treatment decisions in the management of spasticity
22. Spasticity: The fable of a neurological demon and the emperor's new therapy
23. A multicenter, open-label study of the safety and efficacy of repeated botulinum toxin type A doses in poststroke focal, upper limb spasticity